Knockdown of RPL34 suppresses osteosarcoma cell proliferation likely through EIF3/FAU signaling pathway.

Huang, Piwei; Zhao, Jinmin; Fowdur, Mitra; Liu, Yun; Wu, Hao; He, Maolin

Huang, Piwei; Zhao, Jinmin; Fowdur, Mitra; Liu, Yun; Wu, Hao; He, Maolin.

Afiliación

Huang P; Division of Spinal Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530000, China.
Zhao J; Guangxi Biomedical Collaborative Innovation Center, Nanning 530000, China.
Fowdur M; Guangxi Key Laboratory of Regenerative Medicine, Guangxi Medical University, Nanning 530000, China.
Liu Y; Guangxi Key Laboratory of Regenerative Medicine, Guangxi Medical University, Nanning 530000, China.
Wu H; Department of Orthopedic Trauma and Hand Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530000, China.
He M; Division of Spinal Surgery, The First Affiliated Hospital of Guangxi Medical University, Nanning 530000, China.

Transl Cancer Res ; 8(3): 848-855, 2019 Jun.

Article en En | MEDLINE | ID: mdl-35116824

Palabras clave

EIF3; FAU; RPL34; osteosarcoma; signaling pathway

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Transl Cancer Res Año: 2019 Tipo del documento: Article País de afiliación: China Pais de publicación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google